Research output per year
Research output per year
Research output
- 10 results
Search results
-
2022
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Sunder-Plassmann, V., Aksoy, O., Lind, J., Pecherstorfer, M., Vallet, S. & Podar, K., 2022, In: Expert Opinion on Pharmacotherapy. 23, 12, p. 1425-1444 20 p.Research output: Journal article (peer-reviewed) › Review article
1 Citation (Scopus) -
2021
Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma
Pozzi, S., Bari, A., Pecherstorfer, M. & Vallet, S., 01 Oct 2021, In: Cancers. 13, 19, 4978.Research output: Journal article (peer-reviewed) › Review article
Open Access8 Citations (Scopus) -
Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond
Podar, K. & Leleu, X., 01 Oct 2021, In: Cancers. 13, 20, 5154.Research output: Journal article (peer-reviewed) › Review article
Open Access38 Citations (Scopus) -
The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology
Fan, F. & Podar, K., 02 May 2021, In: Cancers. 13, 10, 2326.Research output: Journal article (peer-reviewed) › Review article
Open Access25 Citations (Scopus) -
2019
Emerging protein kinase inhibitors for the treatment of multiple myeloma
Lind, J., Czernilofsky, F., Vallet, S. & Podar, K., 03 Jul 2019, In: Expert Opinion on Emerging Drugs. 24, 3, p. 133-152 20 p.Research output: Journal article (peer-reviewed) › Review article
22 Citations (Scopus) -
Targeting transcription factors in multiple myeloma: evolving therapeutic strategies
Li, S., Vallet, S., Sacco, A., Roccaro, A., Lentzsch, S. & Podar, K., 04 May 2019, In: Expert Opinion on Investigational Drugs. 28, 5, p. 445-462 18 p.Research output: Journal article (peer-reviewed) › Review article
13 Citations (Scopus) -
2018
Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
Vallet, S., Filzmoser, J.-M., Pecherstorfer, M. & Podar, K., Dec 2018, In: Pharmaceutics. 10, 4, 202.Research output: Journal article (peer-reviewed) › Review article
Open Access30 Citations (Scopus) -
2017
Adoptive cell therapy in multiple Myeloma
Vallet, S., Pecherstorfer, M. & Podar, K., 02 Dec 2017, In: Expert Opinion on Biological Therapy. 17, 12, p. 1511-1522 12 p.Research output: Journal article (peer-reviewed) › Review article
10 Citations (Scopus) -
Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma
Podar, K. & Pecherstorfer, M., 24 Jul 2017, In: Expert Opinion on Pharmacotherapy. 18, 11, p. 1061-1079 19 p.Research output: Journal article (peer-reviewed) › Review article
5 Citations (Scopus) -
Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma
Podar, K. & Jager, D., 2017, In: Current Cancer Drug Targets. 17, 9, p. 782-805 24 p.Research output: Journal article (peer-reviewed) › Review article
17 Citations (Scopus)